Research Article

Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study

Table 3

Descriptive analysis of the HT1 diagnosed children’s presenting laboratory results.

Mean (SD)FrequencyPercentage

Full blood count (CBC)
 Low serum hemoglobin level11.33 g/d (2.00)844.4
 Serum platelet217.00 cells/mm3 (120.31)
 Thrombocytopenia738.9
 Thrombocytosis15.6
Blood coagulation studies
 Prolonged PT20.78 seconds (10.53)1477.8
 High INR1.67 (1.03)1477.8
 Prolonged aPTT time (seconds)36.72 seconds (8.64)422.2
Kidney function tests
 Low serum creatinine level0.250 mg/dL (0.104)527.8
 Serum urea (mg/dL) level18 mg/dL (4.68)
  Low422.2
  High15.6
Liver function tests
 High AST level135.67 IU/L (313.52)1583.3
 High ALT level84.06 IU/L (223.30)422.2
 High GGT level64.39 IU/L (43.47)1372.2
 High total protein level6.44 g/dL (0.922)211.1
 Low serum albumin level4.00 g/dL (0.60)633.3
 High serum total bilirubin level2.78 mg/dl (4.85)844.4
 High serum direct bilirubin level1.33 mg/dl (2.47)844.4
Bone profile
 Serum calcium level (normal)9.50 mg/dL (0.62)18100
 Serum phosphate level3.67 mg/dL (1.53)
  Low1372.2
  High15.6
 Low serum vitamin D level18.39 ng/mL (7.28)1266.7
 High ALP level897.7 IU/L (829.1)1055.6
Tumor marker
 High AFP level47807.56 ng/mL (100578.37)1055.6
 High CEA level2.50 ng/mL (1.43)738.9
Plasma studies
 High plasma succinylacetone2.28 μmol/L (2.72)633.3
 High tyrosine level295.39 μmol/L (201.74)1447.72
 Low phenylalanine level47.72 μmol/L (33.74)527.8
 High methionine level58.22 μmol/L (36.18)738.9